Optimum Investment Advisors Abbott Laboratories Transaction History

Optimum Investment Advisors

  • $227 Million
  • Q3 2024

A detailed history of Optimum Investment Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Optimum Investment Advisors holds 2,725 shares of ABT stock, worth $324,138. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,725
Previous 2,725 -0.0%
Holding current value
$324,138
Previous $283,000 9.54%
% of portfolio
0.14%
Previous 0.13%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024
SELL
$90.19 - $110.4 $60,968 - $74,630
-676 Reduced 19.88%
2,725 $299,000
Q3 2023

Oct 13, 2023
BUY
$95.53 - $114.62 $95 - $114
1 Added 0.03%
3,401 $329,000
Q1 2023

May 03, 2023
SELL
$96.86 - $114.01 $74,872 - $88,129
-773 Reduced 18.52%
3,400 $344,000
Q4 2022

Jan 05, 2023
SELL
$95.06 - $111.52 $45,153 - $52,972
-475 Reduced 10.22%
4,173 $0
Q3 2022

Oct 24, 2022
SELL
$96.76 - $112.03 $45,961 - $53,214
-475 Reduced 9.27%
4,648 $450,000
Q1 2022

Apr 08, 2022
SELL
$114.02 - $139.04 $78,559 - $95,798
-689 Reduced 11.85%
5,123 $606,000
Q3 2021

Oct 22, 2021
SELL
$116.66 - $129.06 $40,831 - $45,171
-350 Reduced 5.68%
5,812 $687,000
Q2 2021

Aug 02, 2021
SELL
$105.79 - $124.53 $74,053 - $87,171
-700 Reduced 10.2%
6,162 $714,000
Q4 2020

Jan 21, 2021
SELL
$105.0 - $114.42 $96,810 - $105,495
-922 Reduced 11.84%
6,862 $751,000
Q3 2020

Oct 06, 2020
SELL
$91.64 - $111.29 $71,112 - $86,361
-776 Reduced 9.07%
7,784 $847,000
Q2 2020

Jul 16, 2020
BUY
$76.57 - $98.0 $16,615 - $21,266
217 Added 2.6%
8,560 $783,000
Q1 2020

Apr 21, 2020
SELL
$62.82 - $91.86 $100,072 - $146,332
-1,593 Reduced 16.03%
8,343 $658,000
Q4 2019

Jan 22, 2020
SELL
$78.51 - $87.4 $40,040 - $44,574
-510 Reduced 4.88%
9,936 $863,000
Q3 2019

Oct 17, 2019
SELL
$81.84 - $88.74 $8,184 - $8,874
-100 Reduced 0.95%
10,446 $874,000
Q2 2019

Jul 29, 2019
SELL
$72.88 - $85.0 $20,042 - $23,375
-275 Reduced 2.54%
10,546 $887,000
Q1 2019

May 03, 2019
SELL
$66.22 - $80.06 $23,177 - $28,021
-350 Reduced 3.13%
10,821 $865,000
Q4 2018

Feb 04, 2019
SELL
$65.56 - $74.27 $16,390 - $18,567
-250 Reduced 2.19%
11,171 $808,000
Q3 2018

Oct 05, 2018
SELL
$60.81 - $73.36 $131,714 - $158,897
-2,166 Reduced 15.94%
11,421 $838,000
Q2 2018

Oct 05, 2018
SELL
$57.57 - $63.54 $7,196 - $7,942
-125 Reduced 0.91%
13,587 $829,000
Q1 2018

May 09, 2018
SELL
$56.27 - $63.62 $5,627 - $6,362
-100 Reduced 0.72%
13,712 $822,000
Q3 2017

Nov 21, 2017
BUY
$48.06 - $53.64 $5,430 - $6,061
113 Added 0.82%
13,812 $737,000
Q2 2017

Aug 14, 2017
BUY
N/A
13,699
13,699 $666,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email